sexualised drug use (Chemsex)
Conditions
Interventions
Group 1: MSM with Chemsex
Single survey point: BDI-II, MADRS, CTQ, HBI, RSQ, SCID-5-PD, demographic questionnaire and serum for oxytocin measurement
Group 2: MSM without Chemsex
Single survey point: B
Sponsors
Psychiatrischen Klinik des Klinikums der LMU
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: • Men that have sex with men (MSM) • Consumption of Methamphetamin, Ketamin, GHB/GBL, and/or Mephedron in sexual context during the past 6 Months
Exclusion criteria
Exclusion criteria: • Critical health condition • acute intoxication • Acute suicidality or acute psychotic states
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary goal of this study is to create a psychiatric profile of MSM consuming substances in a sexual context using previously published and validated psychopathology questionnaires. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints of this study include persistence of personality disorders (SIKD-5-PD, BSL-23), and severe depression (clinical diagnosis, BDI, MADRS), history of childhood trauma (CTQ), severity of hypersexual behavior (HBI ), and serum oxytocin levels. | — |
Countries
Germany
Outcome results
None listed